Predict your next investment

FOOD & BEVERAGES | Dairy products
blendandpack.com.au

See what CB Insights has to offer

Stage

Corporate Majority | Acquired

Valuation

$0000 

About Blend and Pack

Blend and Pack is a provider of blending, packaging and distribution services to customers in the infant formula and nutritional products market.

Blend and Pack Headquarter Location

17 Austral Place

Hallam, Victoria, 3803,

Australia

+61 3 8786 3637

Latest Blend and Pack News

ASX infant formula group Wattle Health to raise $39.7 million in new shares

Jan 23, 2020

ASX infant formula group Wattle Health to raise $39.7 million in new shares ASX infant formula company Wattle Health Australia Ltd  (ASX: WHA) shares are closer to returning to market after the group's latest announcement. The Aussie group announced a new share offer to raise $39.7 million in new shares to fund its purchase of Blend and Pack. ASX infant formula company Wattle Health Australia Ltd  (ASX: WHA) shares are closer to returning to market after the group’s latest announcement. What did Wattle Health announce yesterday? The Aussie group announced a new share offer to raise $39.7 million in new shares to fund its purchase of Blend and Pack. Blend and Pack is an Australian dairy products processing and packaging group with a global client base. Wattle Health is seeking to acquire the group to improve its supply chain and penetrate the lucrative Chinese market. According to yesterday’s announcement, the new Wattle Health shares will be offered at $0.40 per share. That’s a steep discount to the group’s $0.53 closing share price from Friday 27 September 2019. The infant formula group’s shares haven’t traded since that date, as Wattle Health looks to tie up its Blend and Pack acquisition. What else did the group announce yesterday? The announcement of new Wattle Health shares wasn’t the only one from the group on Thursday. Wattle Health will start selling its Uganic’s infant formula range across Chemist Warehouse’s retail network in March. The group will also sell its Little Innoscents organic skin care range in Chemist Warehouse stores. Wattle Health issued 4,103,208 fully paid shares under the Chemist Warehouse agreement as per yesterday’s announcement. It’s also been a busy few weeks for the ASX infant formula group with senior leadership changes taking effect. The group appointed Dr Tony McKenna as the Group CEO and Managing Director on 13 January 2020. He replaces co-founder Lazarus Karasavvidis, who resigned from the board and stepped down from the CEO role. This comes as the group looks to kickstart its growth and return to trading on the ASX. Wattle Health’s deal with Blend and Pack has been at a standstill as the group looked to raise the required capital under the terms of the deal. Foolish takeaway Wattle Health shares will certainly be worth watching when they return to trading on the ASX. There’s no indication just yet of when that will be, but it looks like wholesale changes are being made to facilitate the group’s growth going forward. It’s been a big year for the sector with Bellamy’s Australia  being snapped by up China Mengniu Dairy Company . Bubs Australia Ltd (ASX: BUB) and A2 Milk Company Ltd (ASX: A2M) have also enjoyed a strong 12-month period. If you're after more ASX dividend shares in 2020, check out these 3 high-yield options for the right price in 2020. Five Cheap and Good Stocks to Buy in 2020… Our Motley Fool experts have released a fantastic FREE report, detailing 5 dirt cheap shares that you can buy in 2020 and hold for YEARS Simply fill in your email below to scoop up your FREE copy and discover all 5 shares. But you will want to hurry – this free report is available for a brief time only. By clicking this button, you agree to our Terms of Service and Privacy Policy . We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe at anytime. Please refer to our Financial Services Guide (FSG) for more information. Stock Strategies

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.